Global Klebsiella Pneumoniae Infection Drug Market Growth 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
As the global economy mends, the 2021 growth of Klebsiella Pneumoniae Infection Drug will have significant change from previous year. According to our (LP Information) latest study, the global Klebsiella Pneumoniae Infection Drug market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Klebsiella Pneumoniae Infection Drug market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Klebsiella Pneumoniae Infection Drug market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Klebsiella Pneumoniae Infection Drug market, reaching US$ million by the year 2028. As for the Europe Klebsiella Pneumoniae Infection Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Klebsiella Pneumoniae Infection Drug players cover Acies Bio doo, Appili Therapeutics, Debiopharm International SA, and Evaxion Biotech ApS, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Klebsiella Pneumoniae Infection Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
As the global economy mends, the 2021 growth of Klebsiella Pneumoniae Infection Drug will have significant change from previous year. According to our (LP Information) latest study, the global Klebsiella Pneumoniae Infection Drug market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Klebsiella Pneumoniae Infection Drug market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Klebsiella Pneumoniae Infection Drug market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Klebsiella Pneumoniae Infection Drug market, reaching US$ million by the year 2028. As for the Europe Klebsiella Pneumoniae Infection Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Klebsiella Pneumoniae Infection Drug players cover Acies Bio doo, Appili Therapeutics, Debiopharm International SA, and Evaxion Biotech ApS, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Klebsiella Pneumoniae Infection Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
- ATI-1503
- CA-824
- CC-1807
- Cefiderocol
- Debio-1454
- EBX-004
- Others
- Hospital
- Clinic
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Acies Bio doo
- Appili Therapeutics
- Debiopharm International SA
- Evaxion Biotech ApS
- F. Hoffmann-La Roche Ltd
- FOB Synthesis Inc
- ImmunoClin Corp
- Innovation Pharmaceuticals Inc
- Kyorin Pharmaceutical Co Ltd
- Melinta Therapeutics Inc
- Nosopharm SAS
- Peptilogics Inc
- Pfizer Inc
- Phico Therapeutics Ltd
- Sarepta Therapeutics Inc
- Shionogi & Co Ltd
- Syntiron LLC
- Tetraphase Pharmaceuticals Inc
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Klebsiella Pneumoniae Infection Drug Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Klebsiella Pneumoniae Infection Drug by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Klebsiella Pneumoniae Infection Drug by Country/Region, 2017, 2022 & 2028
2.2 Klebsiella Pneumoniae Infection Drug Segment by Type
2.2.1 ATI-1503
2.2.2 CA-824
2.2.3 CC-1807
2.2.4 Cefiderocol
2.2.5 Debio-1454
2.2.6 EBX-004
2.2.7 Others
2.3 Klebsiella Pneumoniae Infection Drug Sales by Type
2.3.1 Global Klebsiella Pneumoniae Infection Drug Sales Market Share by Type (2017-2022)
2.3.2 Global Klebsiella Pneumoniae Infection Drug Revenue and Market Share by Type (2017-2022)
2.3.3 Global Klebsiella Pneumoniae Infection Drug Sale Price by Type (2017-2022)
2.4 Klebsiella Pneumoniae Infection Drug Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Klebsiella Pneumoniae Infection Drug Sales by Application
2.5.1 Global Klebsiella Pneumoniae Infection Drug Sale Market Share by Application (2017-2022)
2.5.2 Global Klebsiella Pneumoniae Infection Drug Revenue and Market Share by Application (2017-2022)
2.5.3 Global Klebsiella Pneumoniae Infection Drug Sale Price by Application (2017-2022)
3 GLOBAL KLEBSIELLA PNEUMONIAE INFECTION DRUG BY COMPANY
3.1 Global Klebsiella Pneumoniae Infection Drug Breakdown Data by Company
3.1.1 Global Klebsiella Pneumoniae Infection Drug Annual Sales by Company (2020-2022)
3.1.2 Global Klebsiella Pneumoniae Infection Drug Sales Market Share by Company (2020-2022)
3.2 Global Klebsiella Pneumoniae Infection Drug Annual Revenue by Company (2020-2022)
3.2.1 Global Klebsiella Pneumoniae Infection Drug Revenue by Company (2020-2022)
3.2.2 Global Klebsiella Pneumoniae Infection Drug Revenue Market Share by Company (2020-2022)
3.3 Global Klebsiella Pneumoniae Infection Drug Sale Price by Company
3.4 Key Manufacturers Klebsiella Pneumoniae Infection Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Klebsiella Pneumoniae Infection Drug Product Location Distribution
3.4.2 Players Klebsiella Pneumoniae Infection Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR KLEBSIELLA PNEUMONIAE INFECTION DRUG BY GEOGRAPHIC REGION
4.1 World Historic Klebsiella Pneumoniae Infection Drug Market Size by Geographic Region (2017-2022)
4.1.1 Global Klebsiella Pneumoniae Infection Drug Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Klebsiella Pneumoniae Infection Drug Annual Revenue by Geographic Region
4.2 World Historic Klebsiella Pneumoniae Infection Drug Market Size by Country/Region (2017-2022)
4.2.1 Global Klebsiella Pneumoniae Infection Drug Annual Sales by Country/Region (2017-2022)
4.2.2 Global Klebsiella Pneumoniae Infection Drug Annual Revenue by Country/Region
4.3 Americas Klebsiella Pneumoniae Infection Drug Sales Growth
4.4 APAC Klebsiella Pneumoniae Infection Drug Sales Growth
4.5 Europe Klebsiella Pneumoniae Infection Drug Sales Growth
4.6 Middle East & Africa Klebsiella Pneumoniae Infection Drug Sales Growth
5 AMERICAS
5.1 Americas Klebsiella Pneumoniae Infection Drug Sales by Country
5.1.1 Americas Klebsiella Pneumoniae Infection Drug Sales by Country (2017-2022)
5.1.2 Americas Klebsiella Pneumoniae Infection Drug Revenue by Country (2017-2022)
5.2 Americas Klebsiella Pneumoniae Infection Drug Sales by Type
5.3 Americas Klebsiella Pneumoniae Infection Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Klebsiella Pneumoniae Infection Drug Sales by Region
6.1.1 APAC Klebsiella Pneumoniae Infection Drug Sales by Region (2017-2022)
6.1.2 APAC Klebsiella Pneumoniae Infection Drug Revenue by Region (2017-2022)
6.2 APAC Klebsiella Pneumoniae Infection Drug Sales by Type
6.3 APAC Klebsiella Pneumoniae Infection Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Klebsiella Pneumoniae Infection Drug by Country
7.1.1 Europe Klebsiella Pneumoniae Infection Drug Sales by Country (2017-2022)
7.1.2 Europe Klebsiella Pneumoniae Infection Drug Revenue by Country (2017-2022)
7.2 Europe Klebsiella Pneumoniae Infection Drug Sales by Type
7.3 Europe Klebsiella Pneumoniae Infection Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Klebsiella Pneumoniae Infection Drug by Country
8.1.1 Middle East & Africa Klebsiella Pneumoniae Infection Drug Sales by Country (2017-2022)
8.1.2 Middle East & Africa Klebsiella Pneumoniae Infection Drug Revenue by Country (2017-2022)
8.2 Middle East & Africa Klebsiella Pneumoniae Infection Drug Sales by Type
8.3 Middle East & Africa Klebsiella Pneumoniae Infection Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Klebsiella Pneumoniae Infection Drug
10.3 Manufacturing Process Analysis of Klebsiella Pneumoniae Infection Drug
10.4 Industry Chain Structure of Klebsiella Pneumoniae Infection Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Klebsiella Pneumoniae Infection Drug Distributors
11.3 Klebsiella Pneumoniae Infection Drug Customer
12 WORLD FORECAST REVIEW FOR KLEBSIELLA PNEUMONIAE INFECTION DRUG BY GEOGRAPHIC REGION
12.1 Global Klebsiella Pneumoniae Infection Drug Market Size Forecast by Region
12.1.1 Global Klebsiella Pneumoniae Infection Drug Forecast by Region (2023-2028)
12.1.2 Global Klebsiella Pneumoniae Infection Drug Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Klebsiella Pneumoniae Infection Drug Forecast by Type
12.7 Global Klebsiella Pneumoniae Infection Drug Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Acies Bio doo
13.1.1 Acies Bio doo Company Information
13.1.2 Acies Bio doo Klebsiella Pneumoniae Infection Drug Product Offered
13.1.3 Acies Bio doo Klebsiella Pneumoniae Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Acies Bio doo Main Business Overview
13.1.5 Acies Bio doo Latest Developments
13.2 Appili Therapeutics
13.2.1 Appili Therapeutics Company Information
13.2.2 Appili Therapeutics Klebsiella Pneumoniae Infection Drug Product Offered
13.2.3 Appili Therapeutics Klebsiella Pneumoniae Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Appili Therapeutics Main Business Overview
13.2.5 Appili Therapeutics Latest Developments
13.3 Debiopharm International SA
13.3.1 Debiopharm International SA Company Information
13.3.2 Debiopharm International SA Klebsiella Pneumoniae Infection Drug Product Offered
13.3.3 Debiopharm International SA Klebsiella Pneumoniae Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Debiopharm International SA Main Business Overview
13.3.5 Debiopharm International SA Latest Developments
13.4 Evaxion Biotech ApS
13.4.1 Evaxion Biotech ApS Company Information
13.4.2 Evaxion Biotech ApS Klebsiella Pneumoniae Infection Drug Product Offered
13.4.3 Evaxion Biotech ApS Klebsiella Pneumoniae Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Evaxion Biotech ApS Main Business Overview
13.4.5 Evaxion Biotech ApS Latest Developments
13.5 F. Hoffmann-La Roche Ltd
13.5.1 F. Hoffmann-La Roche Ltd Company Information
13.5.2 F. Hoffmann-La Roche Ltd Klebsiella Pneumoniae Infection Drug Product Offered
13.5.3 F. Hoffmann-La Roche Ltd Klebsiella Pneumoniae Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 F. Hoffmann-La Roche Ltd Main Business Overview
13.5.5 F. Hoffmann-La Roche Ltd Latest Developments
13.6 FOB Synthesis Inc
13.6.1 FOB Synthesis Inc Company Information
13.6.2 FOB Synthesis Inc Klebsiella Pneumoniae Infection Drug Product Offered
13.6.3 FOB Synthesis Inc Klebsiella Pneumoniae Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 FOB Synthesis Inc Main Business Overview
13.6.5 FOB Synthesis Inc Latest Developments
13.7 ImmunoClin Corp
13.7.1 ImmunoClin Corp Company Information
13.7.2 ImmunoClin Corp Klebsiella Pneumoniae Infection Drug Product Offered
13.7.3 ImmunoClin Corp Klebsiella Pneumoniae Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 ImmunoClin Corp Main Business Overview
13.7.5 ImmunoClin Corp Latest Developments
13.8 Innovation Pharmaceuticals Inc
13.8.1 Innovation Pharmaceuticals Inc Company Information
13.8.2 Innovation Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Product Offered
13.8.3 Innovation Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Innovation Pharmaceuticals Inc Main Business Overview
13.8.5 Innovation Pharmaceuticals Inc Latest Developments
13.9 Kyorin Pharmaceutical Co Ltd
13.9.1 Kyorin Pharmaceutical Co Ltd Company Information
13.9.2 Kyorin Pharmaceutical Co Ltd Klebsiella Pneumoniae Infection Drug Product Offered
13.9.3 Kyorin Pharmaceutical Co Ltd Klebsiella Pneumoniae Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Kyorin Pharmaceutical Co Ltd Main Business Overview
13.9.5 Kyorin Pharmaceutical Co Ltd Latest Developments
13.10 Melinta Therapeutics Inc
13.10.1 Melinta Therapeutics Inc Company Information
13.10.2 Melinta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Product Offered
13.10.3 Melinta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Melinta Therapeutics Inc Main Business Overview
13.10.5 Melinta Therapeutics Inc Latest Developments
13.11 Nosopharm SAS
13.11.1 Nosopharm SAS Company Information
13.11.2 Nosopharm SAS Klebsiella Pneumoniae Infection Drug Product Offered
13.11.3 Nosopharm SAS Klebsiella Pneumoniae Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Nosopharm SAS Main Business Overview
13.11.5 Nosopharm SAS Latest Developments
13.12 Peptilogics Inc
13.12.1 Peptilogics Inc Company Information
13.12.2 Peptilogics Inc Klebsiella Pneumoniae Infection Drug Product Offered
13.12.3 Peptilogics Inc Klebsiella Pneumoniae Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Peptilogics Inc Main Business Overview
13.12.5 Peptilogics Inc Latest Developments
13.13 Pfizer Inc
13.13.1 Pfizer Inc Company Information
13.13.2 Pfizer Inc Klebsiella Pneumoniae Infection Drug Product Offered
13.13.3 Pfizer Inc Klebsiella Pneumoniae Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Pfizer Inc Main Business Overview
13.13.5 Pfizer Inc Latest Developments
13.14 Phico Therapeutics Ltd
13.14.1 Phico Therapeutics Ltd Company Information
13.14.2 Phico Therapeutics Ltd Klebsiella Pneumoniae Infection Drug Product Offered
13.14.3 Phico Therapeutics Ltd Klebsiella Pneumoniae Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Phico Therapeutics Ltd Main Business Overview
13.14.5 Phico Therapeutics Ltd Latest Developments
13.15 Sarepta Therapeutics Inc
13.15.1 Sarepta Therapeutics Inc Company Information
13.15.2 Sarepta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Product Offered
13.15.3 Sarepta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Sarepta Therapeutics Inc Main Business Overview
13.15.5 Sarepta Therapeutics Inc Latest Developments
13.16 Shionogi & Co Ltd
13.16.1 Shionogi & Co Ltd Company Information
13.16.2 Shionogi & Co Ltd Klebsiella Pneumoniae Infection Drug Product Offered
13.16.3 Shionogi & Co Ltd Klebsiella Pneumoniae Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Shionogi & Co Ltd Main Business Overview
13.16.5 Shionogi & Co Ltd Latest Developments
13.17 Syntiron LLC
13.17.1 Syntiron LLC Company Information
13.17.2 Syntiron LLC Klebsiella Pneumoniae Infection Drug Product Offered
13.17.3 Syntiron LLC Klebsiella Pneumoniae Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Syntiron LLC Main Business Overview
13.17.5 Syntiron LLC Latest Developments
13.18 Tetraphase Pharmaceuticals Inc
13.18.1 Tetraphase Pharmaceuticals Inc Company Information
13.18.2 Tetraphase Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Product Offered
13.18.3 Tetraphase Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.18.4 Tetraphase Pharmaceuticals Inc Main Business Overview
13.18.5 Tetraphase Pharmaceuticals Inc Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Klebsiella Pneumoniae Infection Drug Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Klebsiella Pneumoniae Infection Drug by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Klebsiella Pneumoniae Infection Drug by Country/Region, 2017, 2022 & 2028
2.2 Klebsiella Pneumoniae Infection Drug Segment by Type
2.2.1 ATI-1503
2.2.2 CA-824
2.2.3 CC-1807
2.2.4 Cefiderocol
2.2.5 Debio-1454
2.2.6 EBX-004
2.2.7 Others
2.3 Klebsiella Pneumoniae Infection Drug Sales by Type
2.3.1 Global Klebsiella Pneumoniae Infection Drug Sales Market Share by Type (2017-2022)
2.3.2 Global Klebsiella Pneumoniae Infection Drug Revenue and Market Share by Type (2017-2022)
2.3.3 Global Klebsiella Pneumoniae Infection Drug Sale Price by Type (2017-2022)
2.4 Klebsiella Pneumoniae Infection Drug Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Klebsiella Pneumoniae Infection Drug Sales by Application
2.5.1 Global Klebsiella Pneumoniae Infection Drug Sale Market Share by Application (2017-2022)
2.5.2 Global Klebsiella Pneumoniae Infection Drug Revenue and Market Share by Application (2017-2022)
2.5.3 Global Klebsiella Pneumoniae Infection Drug Sale Price by Application (2017-2022)
3 GLOBAL KLEBSIELLA PNEUMONIAE INFECTION DRUG BY COMPANY
3.1 Global Klebsiella Pneumoniae Infection Drug Breakdown Data by Company
3.1.1 Global Klebsiella Pneumoniae Infection Drug Annual Sales by Company (2020-2022)
3.1.2 Global Klebsiella Pneumoniae Infection Drug Sales Market Share by Company (2020-2022)
3.2 Global Klebsiella Pneumoniae Infection Drug Annual Revenue by Company (2020-2022)
3.2.1 Global Klebsiella Pneumoniae Infection Drug Revenue by Company (2020-2022)
3.2.2 Global Klebsiella Pneumoniae Infection Drug Revenue Market Share by Company (2020-2022)
3.3 Global Klebsiella Pneumoniae Infection Drug Sale Price by Company
3.4 Key Manufacturers Klebsiella Pneumoniae Infection Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Klebsiella Pneumoniae Infection Drug Product Location Distribution
3.4.2 Players Klebsiella Pneumoniae Infection Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR KLEBSIELLA PNEUMONIAE INFECTION DRUG BY GEOGRAPHIC REGION
4.1 World Historic Klebsiella Pneumoniae Infection Drug Market Size by Geographic Region (2017-2022)
4.1.1 Global Klebsiella Pneumoniae Infection Drug Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Klebsiella Pneumoniae Infection Drug Annual Revenue by Geographic Region
4.2 World Historic Klebsiella Pneumoniae Infection Drug Market Size by Country/Region (2017-2022)
4.2.1 Global Klebsiella Pneumoniae Infection Drug Annual Sales by Country/Region (2017-2022)
4.2.2 Global Klebsiella Pneumoniae Infection Drug Annual Revenue by Country/Region
4.3 Americas Klebsiella Pneumoniae Infection Drug Sales Growth
4.4 APAC Klebsiella Pneumoniae Infection Drug Sales Growth
4.5 Europe Klebsiella Pneumoniae Infection Drug Sales Growth
4.6 Middle East & Africa Klebsiella Pneumoniae Infection Drug Sales Growth
5 AMERICAS
5.1 Americas Klebsiella Pneumoniae Infection Drug Sales by Country
5.1.1 Americas Klebsiella Pneumoniae Infection Drug Sales by Country (2017-2022)
5.1.2 Americas Klebsiella Pneumoniae Infection Drug Revenue by Country (2017-2022)
5.2 Americas Klebsiella Pneumoniae Infection Drug Sales by Type
5.3 Americas Klebsiella Pneumoniae Infection Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Klebsiella Pneumoniae Infection Drug Sales by Region
6.1.1 APAC Klebsiella Pneumoniae Infection Drug Sales by Region (2017-2022)
6.1.2 APAC Klebsiella Pneumoniae Infection Drug Revenue by Region (2017-2022)
6.2 APAC Klebsiella Pneumoniae Infection Drug Sales by Type
6.3 APAC Klebsiella Pneumoniae Infection Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Klebsiella Pneumoniae Infection Drug by Country
7.1.1 Europe Klebsiella Pneumoniae Infection Drug Sales by Country (2017-2022)
7.1.2 Europe Klebsiella Pneumoniae Infection Drug Revenue by Country (2017-2022)
7.2 Europe Klebsiella Pneumoniae Infection Drug Sales by Type
7.3 Europe Klebsiella Pneumoniae Infection Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Klebsiella Pneumoniae Infection Drug by Country
8.1.1 Middle East & Africa Klebsiella Pneumoniae Infection Drug Sales by Country (2017-2022)
8.1.2 Middle East & Africa Klebsiella Pneumoniae Infection Drug Revenue by Country (2017-2022)
8.2 Middle East & Africa Klebsiella Pneumoniae Infection Drug Sales by Type
8.3 Middle East & Africa Klebsiella Pneumoniae Infection Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Klebsiella Pneumoniae Infection Drug
10.3 Manufacturing Process Analysis of Klebsiella Pneumoniae Infection Drug
10.4 Industry Chain Structure of Klebsiella Pneumoniae Infection Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Klebsiella Pneumoniae Infection Drug Distributors
11.3 Klebsiella Pneumoniae Infection Drug Customer
12 WORLD FORECAST REVIEW FOR KLEBSIELLA PNEUMONIAE INFECTION DRUG BY GEOGRAPHIC REGION
12.1 Global Klebsiella Pneumoniae Infection Drug Market Size Forecast by Region
12.1.1 Global Klebsiella Pneumoniae Infection Drug Forecast by Region (2023-2028)
12.1.2 Global Klebsiella Pneumoniae Infection Drug Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Klebsiella Pneumoniae Infection Drug Forecast by Type
12.7 Global Klebsiella Pneumoniae Infection Drug Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Acies Bio doo
13.1.1 Acies Bio doo Company Information
13.1.2 Acies Bio doo Klebsiella Pneumoniae Infection Drug Product Offered
13.1.3 Acies Bio doo Klebsiella Pneumoniae Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Acies Bio doo Main Business Overview
13.1.5 Acies Bio doo Latest Developments
13.2 Appili Therapeutics
13.2.1 Appili Therapeutics Company Information
13.2.2 Appili Therapeutics Klebsiella Pneumoniae Infection Drug Product Offered
13.2.3 Appili Therapeutics Klebsiella Pneumoniae Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Appili Therapeutics Main Business Overview
13.2.5 Appili Therapeutics Latest Developments
13.3 Debiopharm International SA
13.3.1 Debiopharm International SA Company Information
13.3.2 Debiopharm International SA Klebsiella Pneumoniae Infection Drug Product Offered
13.3.3 Debiopharm International SA Klebsiella Pneumoniae Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Debiopharm International SA Main Business Overview
13.3.5 Debiopharm International SA Latest Developments
13.4 Evaxion Biotech ApS
13.4.1 Evaxion Biotech ApS Company Information
13.4.2 Evaxion Biotech ApS Klebsiella Pneumoniae Infection Drug Product Offered
13.4.3 Evaxion Biotech ApS Klebsiella Pneumoniae Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Evaxion Biotech ApS Main Business Overview
13.4.5 Evaxion Biotech ApS Latest Developments
13.5 F. Hoffmann-La Roche Ltd
13.5.1 F. Hoffmann-La Roche Ltd Company Information
13.5.2 F. Hoffmann-La Roche Ltd Klebsiella Pneumoniae Infection Drug Product Offered
13.5.3 F. Hoffmann-La Roche Ltd Klebsiella Pneumoniae Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 F. Hoffmann-La Roche Ltd Main Business Overview
13.5.5 F. Hoffmann-La Roche Ltd Latest Developments
13.6 FOB Synthesis Inc
13.6.1 FOB Synthesis Inc Company Information
13.6.2 FOB Synthesis Inc Klebsiella Pneumoniae Infection Drug Product Offered
13.6.3 FOB Synthesis Inc Klebsiella Pneumoniae Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 FOB Synthesis Inc Main Business Overview
13.6.5 FOB Synthesis Inc Latest Developments
13.7 ImmunoClin Corp
13.7.1 ImmunoClin Corp Company Information
13.7.2 ImmunoClin Corp Klebsiella Pneumoniae Infection Drug Product Offered
13.7.3 ImmunoClin Corp Klebsiella Pneumoniae Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 ImmunoClin Corp Main Business Overview
13.7.5 ImmunoClin Corp Latest Developments
13.8 Innovation Pharmaceuticals Inc
13.8.1 Innovation Pharmaceuticals Inc Company Information
13.8.2 Innovation Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Product Offered
13.8.3 Innovation Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Innovation Pharmaceuticals Inc Main Business Overview
13.8.5 Innovation Pharmaceuticals Inc Latest Developments
13.9 Kyorin Pharmaceutical Co Ltd
13.9.1 Kyorin Pharmaceutical Co Ltd Company Information
13.9.2 Kyorin Pharmaceutical Co Ltd Klebsiella Pneumoniae Infection Drug Product Offered
13.9.3 Kyorin Pharmaceutical Co Ltd Klebsiella Pneumoniae Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Kyorin Pharmaceutical Co Ltd Main Business Overview
13.9.5 Kyorin Pharmaceutical Co Ltd Latest Developments
13.10 Melinta Therapeutics Inc
13.10.1 Melinta Therapeutics Inc Company Information
13.10.2 Melinta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Product Offered
13.10.3 Melinta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Melinta Therapeutics Inc Main Business Overview
13.10.5 Melinta Therapeutics Inc Latest Developments
13.11 Nosopharm SAS
13.11.1 Nosopharm SAS Company Information
13.11.2 Nosopharm SAS Klebsiella Pneumoniae Infection Drug Product Offered
13.11.3 Nosopharm SAS Klebsiella Pneumoniae Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Nosopharm SAS Main Business Overview
13.11.5 Nosopharm SAS Latest Developments
13.12 Peptilogics Inc
13.12.1 Peptilogics Inc Company Information
13.12.2 Peptilogics Inc Klebsiella Pneumoniae Infection Drug Product Offered
13.12.3 Peptilogics Inc Klebsiella Pneumoniae Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Peptilogics Inc Main Business Overview
13.12.5 Peptilogics Inc Latest Developments
13.13 Pfizer Inc
13.13.1 Pfizer Inc Company Information
13.13.2 Pfizer Inc Klebsiella Pneumoniae Infection Drug Product Offered
13.13.3 Pfizer Inc Klebsiella Pneumoniae Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Pfizer Inc Main Business Overview
13.13.5 Pfizer Inc Latest Developments
13.14 Phico Therapeutics Ltd
13.14.1 Phico Therapeutics Ltd Company Information
13.14.2 Phico Therapeutics Ltd Klebsiella Pneumoniae Infection Drug Product Offered
13.14.3 Phico Therapeutics Ltd Klebsiella Pneumoniae Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Phico Therapeutics Ltd Main Business Overview
13.14.5 Phico Therapeutics Ltd Latest Developments
13.15 Sarepta Therapeutics Inc
13.15.1 Sarepta Therapeutics Inc Company Information
13.15.2 Sarepta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Product Offered
13.15.3 Sarepta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Sarepta Therapeutics Inc Main Business Overview
13.15.5 Sarepta Therapeutics Inc Latest Developments
13.16 Shionogi & Co Ltd
13.16.1 Shionogi & Co Ltd Company Information
13.16.2 Shionogi & Co Ltd Klebsiella Pneumoniae Infection Drug Product Offered
13.16.3 Shionogi & Co Ltd Klebsiella Pneumoniae Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Shionogi & Co Ltd Main Business Overview
13.16.5 Shionogi & Co Ltd Latest Developments
13.17 Syntiron LLC
13.17.1 Syntiron LLC Company Information
13.17.2 Syntiron LLC Klebsiella Pneumoniae Infection Drug Product Offered
13.17.3 Syntiron LLC Klebsiella Pneumoniae Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Syntiron LLC Main Business Overview
13.17.5 Syntiron LLC Latest Developments
13.18 Tetraphase Pharmaceuticals Inc
13.18.1 Tetraphase Pharmaceuticals Inc Company Information
13.18.2 Tetraphase Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Product Offered
13.18.3 Tetraphase Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.18.4 Tetraphase Pharmaceuticals Inc Main Business Overview
13.18.5 Tetraphase Pharmaceuticals Inc Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Klebsiella Pneumoniae Infection Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Klebsiella Pneumoniae Infection Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of ATI-1503
Table 4. Major Players of CA-824
Table 5. Major Players of CC-1807
Table 6. Major Players of Cefiderocol
Table 7. Major Players of Debio-1454
Table 8. Major Players of EBX-004
Table 9. Major Players of Others
Table 10. Global Klebsiella Pneumoniae Infection Drug Sales by Type (2017-2022) & (K Pcs)
Table 11. Global Klebsiella Pneumoniae Infection Drug Sales Market Share by Type (2017-2022)
Table 12. Global Klebsiella Pneumoniae Infection Drug Revenue by Type (2017-2022) & ($ million)
Table 13. Global Klebsiella Pneumoniae Infection Drug Revenue Market Share by Type (2017-2022)
Table 14. Global Klebsiella Pneumoniae Infection Drug Sale Price by Type (2017-2022) & (USD/Pcs)
Table 15. Global Klebsiella Pneumoniae Infection Drug Sales by Application (2017-2022) & (K Pcs)
Table 16. Global Klebsiella Pneumoniae Infection Drug Sales Market Share by Application (2017-2022)
Table 17. Global Klebsiella Pneumoniae Infection Drug Revenue by Application (2017-2022)
Table 18. Global Klebsiella Pneumoniae Infection Drug Revenue Market Share by Application (2017-2022)
Table 19. Global Klebsiella Pneumoniae Infection Drug Sale Price by Application (2017-2022) & (USD/Pcs)
Table 20. Global Klebsiella Pneumoniae Infection Drug Sales by Company (2020-2022) & (K Pcs)
Table 21. Global Klebsiella Pneumoniae Infection Drug Sales Market Share by Company (2020-2022)
Table 22. Global Klebsiella Pneumoniae Infection Drug Revenue by Company (2020-2022) ($ Millions)
Table 23. Global Klebsiella Pneumoniae Infection Drug Revenue Market Share by Company (2020-2022)
Table 24. Global Klebsiella Pneumoniae Infection Drug Sale Price by Company (2020-2022) & (USD/Pcs)
Table 25. Key Manufacturers Klebsiella Pneumoniae Infection Drug Producing Area Distribution and Sales Area
Table 26. Players Klebsiella Pneumoniae Infection Drug Products Offered
Table 27. Klebsiella Pneumoniae Infection Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 28. New Products and Potential Entrants
Table 29. Mergers & Acquisitions, Expansion
Table 30. Global Klebsiella Pneumoniae Infection Drug Sales by Geographic Region (2017-2022) & (K Pcs)
Table 31. Global Klebsiella Pneumoniae Infection Drug Sales Market Share Geographic Region (2017-2022)
Table 32. Global Klebsiella Pneumoniae Infection Drug Revenue by Geographic Region (2017-2022) & ($ millions)
Table 33. Global Klebsiella Pneumoniae Infection Drug Revenue Market Share by Geographic Region (2017-2022)
Table 34. Global Klebsiella Pneumoniae Infection Drug Sales by Country/Region (2017-2022) & (K Pcs)
Table 35. Global Klebsiella Pneumoniae Infection Drug Sales Market Share by Country/Region (2017-2022)
Table 36. Global Klebsiella Pneumoniae Infection Drug Revenue by Country/Region (2017-2022) & ($ millions)
Table 37. Global Klebsiella Pneumoniae Infection Drug Revenue Market Share by Country/Region (2017-2022)
Table 38. Americas Klebsiella Pneumoniae Infection Drug Sales by Country (2017-2022) & (K Pcs)
Table 39. Americas Klebsiella Pneumoniae Infection Drug Sales Market Share by Country (2017-2022)
Table 40. Americas Klebsiella Pneumoniae Infection Drug Revenue by Country (2017-2022) & ($ Millions)
Table 41. Americas Klebsiella Pneumoniae Infection Drug Revenue Market Share by Country (2017-2022)
Table 42. Americas Klebsiella Pneumoniae Infection Drug Sales by Type (2017-2022) & (K Pcs)
Table 43. Americas Klebsiella Pneumoniae Infection Drug Sales Market Share by Type (2017-2022)
Table 44. Americas Klebsiella Pneumoniae Infection Drug Sales by Application (2017-2022) & (K Pcs)
Table 45. Americas Klebsiella Pneumoniae Infection Drug Sales Market Share by Application (2017-2022)
Table 46. APAC Klebsiella Pneumoniae Infection Drug Sales by Region (2017-2022) & (K Pcs)
Table 47. APAC Klebsiella Pneumoniae Infection Drug Sales Market Share by Region (2017-2022)
Table 48. APAC Klebsiella Pneumoniae Infection Drug Revenue by Region (2017-2022) & ($ Millions)
Table 49. APAC Klebsiella Pneumoniae Infection Drug Revenue Market Share by Region (2017-2022)
Table 50. APAC Klebsiella Pneumoniae Infection Drug Sales by Type (2017-2022) & (K Pcs)
Table 51. APAC Klebsiella Pneumoniae Infection Drug Sales Market Share by Type (2017-2022)
Table 52. APAC Klebsiella Pneumoniae Infection Drug Sales by Application (2017-2022) & (K Pcs)
Table 53. APAC Klebsiella Pneumoniae Infection Drug Sales Market Share by Application (2017-2022)
Table 54. Europe Klebsiella Pneumoniae Infection Drug Sales by Country (2017-2022) & (K Pcs)
Table 55. Europe Klebsiella Pneumoniae Infection Drug Sales Market Share by Country (2017-2022)
Table 56. Europe Klebsiella Pneumoniae Infection Drug Revenue by Country (2017-2022) & ($ Millions)
Table 57. Europe Klebsiella Pneumoniae Infection Drug Revenue Market Share by Country (2017-2022)
Table 58. Europe Klebsiella Pneumoniae Infection Drug Sales by Type (2017-2022) & (K Pcs)
Table 59. Europe Klebsiella Pneumoniae Infection Drug Sales Market Share by Type (2017-2022)
Table 60. Europe Klebsiella Pneumoniae Infection Drug Sales by Application (2017-2022) & (K Pcs)
Table 61. Europe Klebsiella Pneumoniae Infection Drug Sales Market Share by Application (2017-2022)
Table 62. Middle East & Africa Klebsiella Pneumoniae Infection Drug Sales by Country (2017-2022) & (K Pcs)
Table 63. Middle East & Africa Klebsiella Pneumoniae Infection Drug Sales Market Share by Country (2017-2022)
Table 64. Middle East & Africa Klebsiella Pneumoniae Infection Drug Revenue by Country (2017-2022) & ($ Millions)
Table 65. Middle East & Africa Klebsiella Pneumoniae Infection Drug Revenue Market Share by Country (2017-2022)
Table 66. Middle East & Africa Klebsiella Pneumoniae Infection Drug Sales by Type (2017-2022) & (K Pcs)
Table 67. Middle East & Africa Klebsiella Pneumoniae Infection Drug Sales Market Share by Type (2017-2022)
Table 68. Middle East & Africa Klebsiella Pneumoniae Infection Drug Sales by Application (2017-2022) & (K Pcs)
Table 69. Middle East & Africa Klebsiella Pneumoniae Infection Drug Sales Market Share by Application (2017-2022)
Table 70. Key Market Drivers & Growth Opportunities of Klebsiella Pneumoniae Infection Drug
Table 71. Key Market Challenges & Risks of Klebsiella Pneumoniae Infection Drug
Table 72. Key Industry Trends of Klebsiella Pneumoniae Infection Drug
Table 73. Klebsiella Pneumoniae Infection Drug Raw Material
Table 74. Key Suppliers of Raw Materials
Table 75. Klebsiella Pneumoniae Infection Drug Distributors List
Table 76. Klebsiella Pneumoniae Infection Drug Customer List
Table 77. Global Klebsiella Pneumoniae Infection Drug Sales Forecast by Region (2023-2028) & (K Pcs)
Table 78. Global Klebsiella Pneumoniae Infection Drug Sales Market Forecast by Region
Table 79. Global Klebsiella Pneumoniae Infection Drug Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Global Klebsiella Pneumoniae Infection Drug Revenue Market Share Forecast by Region (2023-2028)
Table 81. Americas Klebsiella Pneumoniae Infection Drug Sales Forecast by Country (2023-2028) & (K Pcs)
Table 82. Americas Klebsiella Pneumoniae Infection Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. APAC Klebsiella Pneumoniae Infection Drug Sales Forecast by Region (2023-2028) & (K Pcs)
Table 84. APAC Klebsiella Pneumoniae Infection Drug Revenue Forecast by Region (2023-2028) & ($ millions)
Table 85. Europe Klebsiella Pneumoniae Infection Drug Sales Forecast by Country (2023-2028) & (K Pcs)
Table 86. Europe Klebsiella Pneumoniae Infection Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 87. Middle East & Africa Klebsiella Pneumoniae Infection Drug Sales Forecast by Country (2023-2028) & (K Pcs)
Table 88. Middle East & Africa Klebsiella Pneumoniae Infection Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 89. Global Klebsiella Pneumoniae Infection Drug Sales Forecast by Type (2023-2028) & (K Pcs)
Table 90. Global Klebsiella Pneumoniae Infection Drug Sales Market Share Forecast by Type (2023-2028)
Table 91. Global Klebsiella Pneumoniae Infection Drug Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 92. Global Klebsiella Pneumoniae Infection Drug Revenue Market Share Forecast by Type (2023-2028)
Table 93. Global Klebsiella Pneumoniae Infection Drug Sales Forecast by Application (2023-2028) & (K Pcs)
Table 94. Global Klebsiella Pneumoniae Infection Drug Sales Market Share Forecast by Application (2023-2028)
Table 95. Global Klebsiella Pneumoniae Infection Drug Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 96. Global Klebsiella Pneumoniae Infection Drug Revenue Market Share Forecast by Application (2023-2028)
Table 97. Acies Bio doo Basic Information, Klebsiella Pneumoniae Infection Drug Manufacturing Base, Sales Area and Its Competitors
Table 98. Acies Bio doo Klebsiella Pneumoniae Infection Drug Product Offered
Table 99. Acies Bio doo Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 100. Acies Bio doo Main Business
Table 101. Acies Bio doo Latest Developments
Table 102. Appili Therapeutics Basic Information, Klebsiella Pneumoniae Infection Drug Manufacturing Base, Sales Area and Its Competitors
Table 103. Appili Therapeutics Klebsiella Pneumoniae Infection Drug Product Offered
Table 104. Appili Therapeutics Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 105. Appili Therapeutics Main Business
Table 106. Appili Therapeutics Latest Developments
Table 107. Debiopharm International SA Basic Information, Klebsiella Pneumoniae Infection Drug Manufacturing Base, Sales Area and Its Competitors
Table 108. Debiopharm International SA Klebsiella Pneumoniae Infection Drug Product Offered
Table 109. Debiopharm International SA Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 110. Debiopharm International SA Main Business
Table 111. Debiopharm International SA Latest Developments
Table 112. Evaxion Biotech ApS Basic Information, Klebsiella Pneumoniae Infection Drug Manufacturing Base, Sales Area and Its Competitors
Table 113. Evaxion Biotech ApS Klebsiella Pneumoniae Infection Drug Product Offered
Table 114. Evaxion Biotech ApS Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 115. Evaxion Biotech ApS Main Business
Table 116. Evaxion Biotech ApS Latest Developments
Table 117. F. Hoffmann-La Roche Ltd Basic Information, Klebsiella Pneumoniae Infection Drug Manufacturing Base, Sales Area and Its Competitors
Table 118. F. Hoffmann-La Roche Ltd Klebsiella Pneumoniae Infection Drug Product Offered
Table 119. F. Hoffmann-La Roche Ltd Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 120. F. Hoffmann-La Roche Ltd Main Business
Table 121. F. Hoffmann-La Roche Ltd Latest Developments
Table 122. FOB Synthesis Inc Basic Information, Klebsiella Pneumoniae Infection Drug Manufacturing Base, Sales Area and Its Competitors
Table 123. FOB Synthesis Inc Klebsiella Pneumoniae Infection Drug Product Offered
Table 124. FOB Synthesis Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 125. FOB Synthesis Inc Main Business
Table 126. FOB Synthesis Inc Latest Developments
Table 127. ImmunoClin Corp Basic Information, Klebsiella Pneumoniae Infection Drug Manufacturing Base, Sales Area and Its Competitors
Table 128. ImmunoClin Corp Klebsiella Pneumoniae Infection Drug Product Offered
Table 129. ImmunoClin Corp Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 130. ImmunoClin Corp Main Business
Table 131. ImmunoClin Corp Latest Developments
Table 132. Innovation Pharmaceuticals Inc Basic Information, Klebsiella Pneumoniae Infection Drug Manufacturing Base, Sales Area and Its Competitors
Table 133. Innovation Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Product Offered
Table 134. Innovation Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 135. Innovation Pharmaceuticals Inc Main Business
Table 136. Innovation Pharmaceuticals Inc Latest Developments
Table 137. Kyorin Pharmaceutical Co Ltd Basic Information, Klebsiella Pneumoniae Infection Drug Manufacturing Base, Sales Area and Its Competitors
Table 138. Kyorin Pharmaceutical Co Ltd Klebsiella Pneumoniae Infection Drug Product Offered
Table 139. Kyorin Pharmaceutical Co Ltd Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 140. Kyorin Pharmaceutical Co Ltd Main Business
Table 141. Kyorin Pharmaceutical Co Ltd Latest Developments
Table 142. Melinta Therapeutics Inc Basic Information, Klebsiella Pneumoniae Infection Drug Manufacturing Base, Sales Area and Its Competitors
Table 143. Melinta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Product Offered
Table 144. Melinta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 145. Melinta Therapeutics Inc Main Business
Table 146. Melinta Therapeutics Inc Latest Developments
Table 147. Nosopharm SAS Basic Information, Klebsiella Pneumoniae Infection Drug Manufacturing Base, Sales Area and Its Competitors
Table 148. Nosopharm SAS Klebsiella Pneumoniae Infection Drug Product Offered
Table 149. Nosopharm SAS Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 150. Nosopharm SAS Main Business
Table 151. Nosopharm SAS Latest Developments
Table 152. Peptilogics Inc Basic Information, Klebsiella Pneumoniae Infection Drug Manufacturing Base, Sales Area and Its Competitors
Table 153. Peptilogics Inc Klebsiella Pneumoniae Infection Drug Product Offered
Table 154. Peptilogics Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 155. Peptilogics Inc Main Business
Table 156. Peptilogics Inc Latest Developments
Table 157. Pfizer Inc Basic Information, Klebsiella Pneumoniae Infection Drug Manufacturing Base, Sales Area and Its Competitors
Table 158. Pfizer Inc Klebsiella Pneumoniae Infection Drug Product Offered
Table 159. Pfizer Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 160. Pfizer Inc Main Business
Table 161. Pfizer Inc Latest Developments
Table 162. Phico Therapeutics Ltd Basic Information, Klebsiella Pneumoniae Infection Drug Manufacturing Base, Sales Area and Its Competitors
Table 163. Phico Therapeutics Ltd Klebsiella Pneumoniae Infection Drug Product Offered
Table 164. Phico Therapeutics Ltd Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 165. Phico Therapeutics Ltd Main Business
Table 166. Phico Therapeutics Ltd Latest Developments
Table 167. Sarepta Therapeutics Inc Basic Information, Klebsiella Pneumoniae Infection Drug Manufacturing Base, Sales Area and Its Competitors
Table 168. Sarepta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Product Offered
Table 169. Sarepta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 170. Sarepta Therapeutics Inc Main Business
Table 171. Sarepta Therapeutics Inc Latest Developments
Table 172. Shionogi & Co Ltd Basic Information, Klebsiella Pneumoniae Infection Drug Manufacturing Base, Sales Area and Its Competitors
Table 173. Shionogi & Co Ltd Klebsiella Pneumoniae Infection Drug Product Offered
Table 174. Shionogi & Co Ltd Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 175. Shionogi & Co Ltd Main Business
Table 176. Shionogi & Co Ltd Latest Developments
Table 177. Syntiron LLC Basic Information, Klebsiella Pneumoniae Infection Drug Manufacturing Base, Sales Area and Its Competitors
Table 178. Syntiron LLC Klebsiella Pneumoniae Infection Drug Product Offered
Table 179. Syntiron LLC Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 180. Syntiron LLC Main Business
Table 181. Syntiron LLC Latest Developments
Table 182. Tetraphase Pharmaceuticals Inc Basic Information, Klebsiella Pneumoniae Infection Drug Manufacturing Base, Sales Area and Its Competitors
Table 183. Tetraphase Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Product Offered
Table 184. Tetraphase Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 185. Tetraphase Pharmaceuticals Inc Main Business
Table 186. Tetraphase Pharmaceuticals Inc Latest Developments
Table 1. Klebsiella Pneumoniae Infection Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Klebsiella Pneumoniae Infection Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of ATI-1503
Table 4. Major Players of CA-824
Table 5. Major Players of CC-1807
Table 6. Major Players of Cefiderocol
Table 7. Major Players of Debio-1454
Table 8. Major Players of EBX-004
Table 9. Major Players of Others
Table 10. Global Klebsiella Pneumoniae Infection Drug Sales by Type (2017-2022) & (K Pcs)
Table 11. Global Klebsiella Pneumoniae Infection Drug Sales Market Share by Type (2017-2022)
Table 12. Global Klebsiella Pneumoniae Infection Drug Revenue by Type (2017-2022) & ($ million)
Table 13. Global Klebsiella Pneumoniae Infection Drug Revenue Market Share by Type (2017-2022)
Table 14. Global Klebsiella Pneumoniae Infection Drug Sale Price by Type (2017-2022) & (USD/Pcs)
Table 15. Global Klebsiella Pneumoniae Infection Drug Sales by Application (2017-2022) & (K Pcs)
Table 16. Global Klebsiella Pneumoniae Infection Drug Sales Market Share by Application (2017-2022)
Table 17. Global Klebsiella Pneumoniae Infection Drug Revenue by Application (2017-2022)
Table 18. Global Klebsiella Pneumoniae Infection Drug Revenue Market Share by Application (2017-2022)
Table 19. Global Klebsiella Pneumoniae Infection Drug Sale Price by Application (2017-2022) & (USD/Pcs)
Table 20. Global Klebsiella Pneumoniae Infection Drug Sales by Company (2020-2022) & (K Pcs)
Table 21. Global Klebsiella Pneumoniae Infection Drug Sales Market Share by Company (2020-2022)
Table 22. Global Klebsiella Pneumoniae Infection Drug Revenue by Company (2020-2022) ($ Millions)
Table 23. Global Klebsiella Pneumoniae Infection Drug Revenue Market Share by Company (2020-2022)
Table 24. Global Klebsiella Pneumoniae Infection Drug Sale Price by Company (2020-2022) & (USD/Pcs)
Table 25. Key Manufacturers Klebsiella Pneumoniae Infection Drug Producing Area Distribution and Sales Area
Table 26. Players Klebsiella Pneumoniae Infection Drug Products Offered
Table 27. Klebsiella Pneumoniae Infection Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 28. New Products and Potential Entrants
Table 29. Mergers & Acquisitions, Expansion
Table 30. Global Klebsiella Pneumoniae Infection Drug Sales by Geographic Region (2017-2022) & (K Pcs)
Table 31. Global Klebsiella Pneumoniae Infection Drug Sales Market Share Geographic Region (2017-2022)
Table 32. Global Klebsiella Pneumoniae Infection Drug Revenue by Geographic Region (2017-2022) & ($ millions)
Table 33. Global Klebsiella Pneumoniae Infection Drug Revenue Market Share by Geographic Region (2017-2022)
Table 34. Global Klebsiella Pneumoniae Infection Drug Sales by Country/Region (2017-2022) & (K Pcs)
Table 35. Global Klebsiella Pneumoniae Infection Drug Sales Market Share by Country/Region (2017-2022)
Table 36. Global Klebsiella Pneumoniae Infection Drug Revenue by Country/Region (2017-2022) & ($ millions)
Table 37. Global Klebsiella Pneumoniae Infection Drug Revenue Market Share by Country/Region (2017-2022)
Table 38. Americas Klebsiella Pneumoniae Infection Drug Sales by Country (2017-2022) & (K Pcs)
Table 39. Americas Klebsiella Pneumoniae Infection Drug Sales Market Share by Country (2017-2022)
Table 40. Americas Klebsiella Pneumoniae Infection Drug Revenue by Country (2017-2022) & ($ Millions)
Table 41. Americas Klebsiella Pneumoniae Infection Drug Revenue Market Share by Country (2017-2022)
Table 42. Americas Klebsiella Pneumoniae Infection Drug Sales by Type (2017-2022) & (K Pcs)
Table 43. Americas Klebsiella Pneumoniae Infection Drug Sales Market Share by Type (2017-2022)
Table 44. Americas Klebsiella Pneumoniae Infection Drug Sales by Application (2017-2022) & (K Pcs)
Table 45. Americas Klebsiella Pneumoniae Infection Drug Sales Market Share by Application (2017-2022)
Table 46. APAC Klebsiella Pneumoniae Infection Drug Sales by Region (2017-2022) & (K Pcs)
Table 47. APAC Klebsiella Pneumoniae Infection Drug Sales Market Share by Region (2017-2022)
Table 48. APAC Klebsiella Pneumoniae Infection Drug Revenue by Region (2017-2022) & ($ Millions)
Table 49. APAC Klebsiella Pneumoniae Infection Drug Revenue Market Share by Region (2017-2022)
Table 50. APAC Klebsiella Pneumoniae Infection Drug Sales by Type (2017-2022) & (K Pcs)
Table 51. APAC Klebsiella Pneumoniae Infection Drug Sales Market Share by Type (2017-2022)
Table 52. APAC Klebsiella Pneumoniae Infection Drug Sales by Application (2017-2022) & (K Pcs)
Table 53. APAC Klebsiella Pneumoniae Infection Drug Sales Market Share by Application (2017-2022)
Table 54. Europe Klebsiella Pneumoniae Infection Drug Sales by Country (2017-2022) & (K Pcs)
Table 55. Europe Klebsiella Pneumoniae Infection Drug Sales Market Share by Country (2017-2022)
Table 56. Europe Klebsiella Pneumoniae Infection Drug Revenue by Country (2017-2022) & ($ Millions)
Table 57. Europe Klebsiella Pneumoniae Infection Drug Revenue Market Share by Country (2017-2022)
Table 58. Europe Klebsiella Pneumoniae Infection Drug Sales by Type (2017-2022) & (K Pcs)
Table 59. Europe Klebsiella Pneumoniae Infection Drug Sales Market Share by Type (2017-2022)
Table 60. Europe Klebsiella Pneumoniae Infection Drug Sales by Application (2017-2022) & (K Pcs)
Table 61. Europe Klebsiella Pneumoniae Infection Drug Sales Market Share by Application (2017-2022)
Table 62. Middle East & Africa Klebsiella Pneumoniae Infection Drug Sales by Country (2017-2022) & (K Pcs)
Table 63. Middle East & Africa Klebsiella Pneumoniae Infection Drug Sales Market Share by Country (2017-2022)
Table 64. Middle East & Africa Klebsiella Pneumoniae Infection Drug Revenue by Country (2017-2022) & ($ Millions)
Table 65. Middle East & Africa Klebsiella Pneumoniae Infection Drug Revenue Market Share by Country (2017-2022)
Table 66. Middle East & Africa Klebsiella Pneumoniae Infection Drug Sales by Type (2017-2022) & (K Pcs)
Table 67. Middle East & Africa Klebsiella Pneumoniae Infection Drug Sales Market Share by Type (2017-2022)
Table 68. Middle East & Africa Klebsiella Pneumoniae Infection Drug Sales by Application (2017-2022) & (K Pcs)
Table 69. Middle East & Africa Klebsiella Pneumoniae Infection Drug Sales Market Share by Application (2017-2022)
Table 70. Key Market Drivers & Growth Opportunities of Klebsiella Pneumoniae Infection Drug
Table 71. Key Market Challenges & Risks of Klebsiella Pneumoniae Infection Drug
Table 72. Key Industry Trends of Klebsiella Pneumoniae Infection Drug
Table 73. Klebsiella Pneumoniae Infection Drug Raw Material
Table 74. Key Suppliers of Raw Materials
Table 75. Klebsiella Pneumoniae Infection Drug Distributors List
Table 76. Klebsiella Pneumoniae Infection Drug Customer List
Table 77. Global Klebsiella Pneumoniae Infection Drug Sales Forecast by Region (2023-2028) & (K Pcs)
Table 78. Global Klebsiella Pneumoniae Infection Drug Sales Market Forecast by Region
Table 79. Global Klebsiella Pneumoniae Infection Drug Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Global Klebsiella Pneumoniae Infection Drug Revenue Market Share Forecast by Region (2023-2028)
Table 81. Americas Klebsiella Pneumoniae Infection Drug Sales Forecast by Country (2023-2028) & (K Pcs)
Table 82. Americas Klebsiella Pneumoniae Infection Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. APAC Klebsiella Pneumoniae Infection Drug Sales Forecast by Region (2023-2028) & (K Pcs)
Table 84. APAC Klebsiella Pneumoniae Infection Drug Revenue Forecast by Region (2023-2028) & ($ millions)
Table 85. Europe Klebsiella Pneumoniae Infection Drug Sales Forecast by Country (2023-2028) & (K Pcs)
Table 86. Europe Klebsiella Pneumoniae Infection Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 87. Middle East & Africa Klebsiella Pneumoniae Infection Drug Sales Forecast by Country (2023-2028) & (K Pcs)
Table 88. Middle East & Africa Klebsiella Pneumoniae Infection Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 89. Global Klebsiella Pneumoniae Infection Drug Sales Forecast by Type (2023-2028) & (K Pcs)
Table 90. Global Klebsiella Pneumoniae Infection Drug Sales Market Share Forecast by Type (2023-2028)
Table 91. Global Klebsiella Pneumoniae Infection Drug Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 92. Global Klebsiella Pneumoniae Infection Drug Revenue Market Share Forecast by Type (2023-2028)
Table 93. Global Klebsiella Pneumoniae Infection Drug Sales Forecast by Application (2023-2028) & (K Pcs)
Table 94. Global Klebsiella Pneumoniae Infection Drug Sales Market Share Forecast by Application (2023-2028)
Table 95. Global Klebsiella Pneumoniae Infection Drug Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 96. Global Klebsiella Pneumoniae Infection Drug Revenue Market Share Forecast by Application (2023-2028)
Table 97. Acies Bio doo Basic Information, Klebsiella Pneumoniae Infection Drug Manufacturing Base, Sales Area and Its Competitors
Table 98. Acies Bio doo Klebsiella Pneumoniae Infection Drug Product Offered
Table 99. Acies Bio doo Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 100. Acies Bio doo Main Business
Table 101. Acies Bio doo Latest Developments
Table 102. Appili Therapeutics Basic Information, Klebsiella Pneumoniae Infection Drug Manufacturing Base, Sales Area and Its Competitors
Table 103. Appili Therapeutics Klebsiella Pneumoniae Infection Drug Product Offered
Table 104. Appili Therapeutics Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 105. Appili Therapeutics Main Business
Table 106. Appili Therapeutics Latest Developments
Table 107. Debiopharm International SA Basic Information, Klebsiella Pneumoniae Infection Drug Manufacturing Base, Sales Area and Its Competitors
Table 108. Debiopharm International SA Klebsiella Pneumoniae Infection Drug Product Offered
Table 109. Debiopharm International SA Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 110. Debiopharm International SA Main Business
Table 111. Debiopharm International SA Latest Developments
Table 112. Evaxion Biotech ApS Basic Information, Klebsiella Pneumoniae Infection Drug Manufacturing Base, Sales Area and Its Competitors
Table 113. Evaxion Biotech ApS Klebsiella Pneumoniae Infection Drug Product Offered
Table 114. Evaxion Biotech ApS Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 115. Evaxion Biotech ApS Main Business
Table 116. Evaxion Biotech ApS Latest Developments
Table 117. F. Hoffmann-La Roche Ltd Basic Information, Klebsiella Pneumoniae Infection Drug Manufacturing Base, Sales Area and Its Competitors
Table 118. F. Hoffmann-La Roche Ltd Klebsiella Pneumoniae Infection Drug Product Offered
Table 119. F. Hoffmann-La Roche Ltd Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 120. F. Hoffmann-La Roche Ltd Main Business
Table 121. F. Hoffmann-La Roche Ltd Latest Developments
Table 122. FOB Synthesis Inc Basic Information, Klebsiella Pneumoniae Infection Drug Manufacturing Base, Sales Area and Its Competitors
Table 123. FOB Synthesis Inc Klebsiella Pneumoniae Infection Drug Product Offered
Table 124. FOB Synthesis Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 125. FOB Synthesis Inc Main Business
Table 126. FOB Synthesis Inc Latest Developments
Table 127. ImmunoClin Corp Basic Information, Klebsiella Pneumoniae Infection Drug Manufacturing Base, Sales Area and Its Competitors
Table 128. ImmunoClin Corp Klebsiella Pneumoniae Infection Drug Product Offered
Table 129. ImmunoClin Corp Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 130. ImmunoClin Corp Main Business
Table 131. ImmunoClin Corp Latest Developments
Table 132. Innovation Pharmaceuticals Inc Basic Information, Klebsiella Pneumoniae Infection Drug Manufacturing Base, Sales Area and Its Competitors
Table 133. Innovation Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Product Offered
Table 134. Innovation Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 135. Innovation Pharmaceuticals Inc Main Business
Table 136. Innovation Pharmaceuticals Inc Latest Developments
Table 137. Kyorin Pharmaceutical Co Ltd Basic Information, Klebsiella Pneumoniae Infection Drug Manufacturing Base, Sales Area and Its Competitors
Table 138. Kyorin Pharmaceutical Co Ltd Klebsiella Pneumoniae Infection Drug Product Offered
Table 139. Kyorin Pharmaceutical Co Ltd Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 140. Kyorin Pharmaceutical Co Ltd Main Business
Table 141. Kyorin Pharmaceutical Co Ltd Latest Developments
Table 142. Melinta Therapeutics Inc Basic Information, Klebsiella Pneumoniae Infection Drug Manufacturing Base, Sales Area and Its Competitors
Table 143. Melinta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Product Offered
Table 144. Melinta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 145. Melinta Therapeutics Inc Main Business
Table 146. Melinta Therapeutics Inc Latest Developments
Table 147. Nosopharm SAS Basic Information, Klebsiella Pneumoniae Infection Drug Manufacturing Base, Sales Area and Its Competitors
Table 148. Nosopharm SAS Klebsiella Pneumoniae Infection Drug Product Offered
Table 149. Nosopharm SAS Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 150. Nosopharm SAS Main Business
Table 151. Nosopharm SAS Latest Developments
Table 152. Peptilogics Inc Basic Information, Klebsiella Pneumoniae Infection Drug Manufacturing Base, Sales Area and Its Competitors
Table 153. Peptilogics Inc Klebsiella Pneumoniae Infection Drug Product Offered
Table 154. Peptilogics Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 155. Peptilogics Inc Main Business
Table 156. Peptilogics Inc Latest Developments
Table 157. Pfizer Inc Basic Information, Klebsiella Pneumoniae Infection Drug Manufacturing Base, Sales Area and Its Competitors
Table 158. Pfizer Inc Klebsiella Pneumoniae Infection Drug Product Offered
Table 159. Pfizer Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 160. Pfizer Inc Main Business
Table 161. Pfizer Inc Latest Developments
Table 162. Phico Therapeutics Ltd Basic Information, Klebsiella Pneumoniae Infection Drug Manufacturing Base, Sales Area and Its Competitors
Table 163. Phico Therapeutics Ltd Klebsiella Pneumoniae Infection Drug Product Offered
Table 164. Phico Therapeutics Ltd Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 165. Phico Therapeutics Ltd Main Business
Table 166. Phico Therapeutics Ltd Latest Developments
Table 167. Sarepta Therapeutics Inc Basic Information, Klebsiella Pneumoniae Infection Drug Manufacturing Base, Sales Area and Its Competitors
Table 168. Sarepta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Product Offered
Table 169. Sarepta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 170. Sarepta Therapeutics Inc Main Business
Table 171. Sarepta Therapeutics Inc Latest Developments
Table 172. Shionogi & Co Ltd Basic Information, Klebsiella Pneumoniae Infection Drug Manufacturing Base, Sales Area and Its Competitors
Table 173. Shionogi & Co Ltd Klebsiella Pneumoniae Infection Drug Product Offered
Table 174. Shionogi & Co Ltd Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 175. Shionogi & Co Ltd Main Business
Table 176. Shionogi & Co Ltd Latest Developments
Table 177. Syntiron LLC Basic Information, Klebsiella Pneumoniae Infection Drug Manufacturing Base, Sales Area and Its Competitors
Table 178. Syntiron LLC Klebsiella Pneumoniae Infection Drug Product Offered
Table 179. Syntiron LLC Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 180. Syntiron LLC Main Business
Table 181. Syntiron LLC Latest Developments
Table 182. Tetraphase Pharmaceuticals Inc Basic Information, Klebsiella Pneumoniae Infection Drug Manufacturing Base, Sales Area and Its Competitors
Table 183. Tetraphase Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Product Offered
Table 184. Tetraphase Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 185. Tetraphase Pharmaceuticals Inc Main Business
Table 186. Tetraphase Pharmaceuticals Inc Latest Developments
LIST OF FIGURES
Figure 1. Picture of Klebsiella Pneumoniae Infection Drug
Figure 2. Klebsiella Pneumoniae Infection Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Klebsiella Pneumoniae Infection Drug Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Klebsiella Pneumoniae Infection Drug Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Klebsiella Pneumoniae Infection Drug Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of ATI-1503
Figure 10. Product Picture of CA-824
Figure 11. Product Picture of CC-1807
Figure 12. Product Picture of Cefiderocol
Figure 13. Product Picture of Debio-1454
Figure 14. Product Picture of EBX-004
Figure 15. Product Picture of Others
Figure 16. Global Klebsiella Pneumoniae Infection Drug Sales Market Share by Type in 2021
Figure 17. Global Klebsiella Pneumoniae Infection Drug Revenue Market Share by Type (2017-2022)
Figure 18. Klebsiella Pneumoniae Infection Drug Consumed in Hospital
Figure 19. Global Klebsiella Pneumoniae Infection Drug Market: Hospital (2017-2022) & (K Pcs)
Figure 20. Klebsiella Pneumoniae Infection Drug Consumed in Clinic
Figure 21. Global Klebsiella Pneumoniae Infection Drug Market: Clinic (2017-2022) & (K Pcs)
Figure 22. Klebsiella Pneumoniae Infection Drug Consumed in Others
Figure 23. Global Klebsiella Pneumoniae Infection Drug Market: Others (2017-2022) & (K Pcs)
Figure 24. Global Klebsiella Pneumoniae Infection Drug Sales Market Share by Application (2017-2022)
Figure 25. Global Klebsiella Pneumoniae Infection Drug Revenue Market Share by Application in 2021
Figure 26. Klebsiella Pneumoniae Infection Drug Revenue Market by Company in 2021 ($ Million)
Figure 27. Global Klebsiella Pneumoniae Infection Drug Revenue Market Share by Company in 2021
Figure 28. Global Klebsiella Pneumoniae Infection Drug Sales Market Share by Geographic Region (2017-2022)
Figure 29. Global Klebsiella Pneumoniae Infection Drug Revenue Market Share by Geographic Region in 2021
Figure 30. Global Klebsiella Pneumoniae Infection Drug Sales Market Share by Region (2017-2022)
Figure 31. Global Klebsiella Pneumoniae Infection Drug Revenue Market Share by Country/Region in 2021
Figure 32. Americas Klebsiella Pneumoniae Infection Drug Sales 2017-2022 (K Pcs)
Figure 33. Americas Klebsiella Pneumoniae Infection Drug Revenue 2017-2022 ($ Millions)
Figure 34. APAC Klebsiella Pneumoniae Infection Drug Sales 2017-2022 (K Pcs)
Figure 35. APAC Klebsiella Pneumoniae Infection Drug Revenue 2017-2022 ($ Millions)
Figure 36. Europe Klebsiella Pneumoniae Infection Drug Sales 2017-2022 (K Pcs)
Figure 37. Europe Klebsiella Pneumoniae Infection Drug Revenue 2017-2022 ($ Millions)
Figure 38. Middle East & Africa Klebsiella Pneumoniae Infection Drug Sales 2017-2022 (K Pcs)
Figure 39. Middle East & Africa Klebsiella Pneumoniae Infection Drug Revenue 2017-2022 ($ Millions)
Figure 40. Americas Klebsiella Pneumoniae Infection Drug Sales Market Share by Country in 2021
Figure 41. Americas Klebsiella Pneumoniae Infection Drug Revenue Market Share by Country in 2021
Figure 42. United States Klebsiella Pneumoniae Infection Drug Revenue Growth 2017-2022 ($ Millions)
Figure 43. Canada Klebsiella Pneumoniae Infection Drug Revenue Growth 2017-2022 ($ Millions)
Figure 44. Mexico Klebsiella Pneumoniae Infection Drug Revenue Growth 2017-2022 ($ Millions)
Figure 45. Brazil Klebsiella Pneumoniae Infection Drug Revenue Growth 2017-2022 ($ Millions)
Figure 46. APAC Klebsiella Pneumoniae Infection Drug Sales Market Share by Region in 2021
Figure 47. APAC Klebsiella Pneumoniae Infection Drug Revenue Market Share by Regions in 2021
Figure 48. China Klebsiella Pneumoniae Infection Drug Revenue Growth 2017-2022 ($ Millions)
Figure 49. Japan Klebsiella Pneumoniae Infection Drug Revenue Growth 2017-2022 ($ Millions)
Figure 50. South Korea Klebsiella Pneumoniae Infection Drug Revenue Growth 2017-2022 ($ Millions)
Figure 51. Southeast Asia Klebsiella Pneumoniae Infection Drug Revenue Growth 2017-2022 ($ Millions)
Figure 52. India Klebsiella Pneumoniae Infection Drug Revenue Growth 2017-2022 ($ Millions)
Figure 53. Australia Klebsiella Pneumoniae Infection Drug Revenue Growth 2017-2022 ($ Millions)
Figure 54. Europe Klebsiella Pneumoniae Infection Drug Sales Market Share by Country in 2021
Figure 55. Europe Klebsiella Pneumoniae Infection Drug Revenue Market Share by Country in 2021
Figure 56. Germany Klebsiella Pneumoniae Infection Drug Revenue Growth 2017-2022 ($ Millions)
Figure 57. France Klebsiella Pneumoniae Infection Drug Revenue Growth 2017-2022 ($ Millions)
Figure 58. UK Klebsiella Pneumoniae Infection Drug Revenue Growth 2017-2022 ($ Millions)
Figure 59. Italy Klebsiella Pneumoniae Infection Drug Revenue Growth 2017-2022 ($ Millions)
Figure 60. Russia Klebsiella Pneumoniae Infection Drug Revenue Growth 2017-2022 ($ Millions)
Figure 61. Middle East & Africa Klebsiella Pneumoniae Infection Drug Sales Market Share by Country in 2021
Figure 62. Middle East & Africa Klebsiella Pneumoniae Infection Drug Revenue Market Share by Country in 2021
Figure 63. Egypt Klebsiella Pneumoniae Infection Drug Revenue Growth 2017-2022 ($ Millions)
Figure 64. South Africa Klebsiella Pneumoniae Infection Drug Revenue Growth 2017-2022 ($ Millions)
Figure 65. Israel Klebsiella Pneumoniae Infection Drug Revenue Growth 2017-2022 ($ Millions)
Figure 66. Turkey Klebsiella Pneumoniae Infection Drug Revenue Growth 2017-2022 ($ Millions)
Figure 67. GCC Country Klebsiella Pneumoniae Infection Drug Revenue Growth 2017-2022 ($ Millions)
Figure 68. Manufacturing Cost Structure Analysis of Klebsiella Pneumoniae Infection Drug in 2021
Figure 69. Manufacturing Process Analysis of Klebsiella Pneumoniae Infection Drug
Figure 70. Industry Chain Structure of Klebsiella Pneumoniae Infection Drug
Figure 71. Channels of Distribution
Figure 72. Distributors Profiles
Figure 1. Picture of Klebsiella Pneumoniae Infection Drug
Figure 2. Klebsiella Pneumoniae Infection Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Klebsiella Pneumoniae Infection Drug Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Klebsiella Pneumoniae Infection Drug Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Klebsiella Pneumoniae Infection Drug Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of ATI-1503
Figure 10. Product Picture of CA-824
Figure 11. Product Picture of CC-1807
Figure 12. Product Picture of Cefiderocol
Figure 13. Product Picture of Debio-1454
Figure 14. Product Picture of EBX-004
Figure 15. Product Picture of Others
Figure 16. Global Klebsiella Pneumoniae Infection Drug Sales Market Share by Type in 2021
Figure 17. Global Klebsiella Pneumoniae Infection Drug Revenue Market Share by Type (2017-2022)
Figure 18. Klebsiella Pneumoniae Infection Drug Consumed in Hospital
Figure 19. Global Klebsiella Pneumoniae Infection Drug Market: Hospital (2017-2022) & (K Pcs)
Figure 20. Klebsiella Pneumoniae Infection Drug Consumed in Clinic
Figure 21. Global Klebsiella Pneumoniae Infection Drug Market: Clinic (2017-2022) & (K Pcs)
Figure 22. Klebsiella Pneumoniae Infection Drug Consumed in Others
Figure 23. Global Klebsiella Pneumoniae Infection Drug Market: Others (2017-2022) & (K Pcs)
Figure 24. Global Klebsiella Pneumoniae Infection Drug Sales Market Share by Application (2017-2022)
Figure 25. Global Klebsiella Pneumoniae Infection Drug Revenue Market Share by Application in 2021
Figure 26. Klebsiella Pneumoniae Infection Drug Revenue Market by Company in 2021 ($ Million)
Figure 27. Global Klebsiella Pneumoniae Infection Drug Revenue Market Share by Company in 2021
Figure 28. Global Klebsiella Pneumoniae Infection Drug Sales Market Share by Geographic Region (2017-2022)
Figure 29. Global Klebsiella Pneumoniae Infection Drug Revenue Market Share by Geographic Region in 2021
Figure 30. Global Klebsiella Pneumoniae Infection Drug Sales Market Share by Region (2017-2022)
Figure 31. Global Klebsiella Pneumoniae Infection Drug Revenue Market Share by Country/Region in 2021
Figure 32. Americas Klebsiella Pneumoniae Infection Drug Sales 2017-2022 (K Pcs)
Figure 33. Americas Klebsiella Pneumoniae Infection Drug Revenue 2017-2022 ($ Millions)
Figure 34. APAC Klebsiella Pneumoniae Infection Drug Sales 2017-2022 (K Pcs)
Figure 35. APAC Klebsiella Pneumoniae Infection Drug Revenue 2017-2022 ($ Millions)
Figure 36. Europe Klebsiella Pneumoniae Infection Drug Sales 2017-2022 (K Pcs)
Figure 37. Europe Klebsiella Pneumoniae Infection Drug Revenue 2017-2022 ($ Millions)
Figure 38. Middle East & Africa Klebsiella Pneumoniae Infection Drug Sales 2017-2022 (K Pcs)
Figure 39. Middle East & Africa Klebsiella Pneumoniae Infection Drug Revenue 2017-2022 ($ Millions)
Figure 40. Americas Klebsiella Pneumoniae Infection Drug Sales Market Share by Country in 2021
Figure 41. Americas Klebsiella Pneumoniae Infection Drug Revenue Market Share by Country in 2021
Figure 42. United States Klebsiella Pneumoniae Infection Drug Revenue Growth 2017-2022 ($ Millions)
Figure 43. Canada Klebsiella Pneumoniae Infection Drug Revenue Growth 2017-2022 ($ Millions)
Figure 44. Mexico Klebsiella Pneumoniae Infection Drug Revenue Growth 2017-2022 ($ Millions)
Figure 45. Brazil Klebsiella Pneumoniae Infection Drug Revenue Growth 2017-2022 ($ Millions)
Figure 46. APAC Klebsiella Pneumoniae Infection Drug Sales Market Share by Region in 2021
Figure 47. APAC Klebsiella Pneumoniae Infection Drug Revenue Market Share by Regions in 2021
Figure 48. China Klebsiella Pneumoniae Infection Drug Revenue Growth 2017-2022 ($ Millions)
Figure 49. Japan Klebsiella Pneumoniae Infection Drug Revenue Growth 2017-2022 ($ Millions)
Figure 50. South Korea Klebsiella Pneumoniae Infection Drug Revenue Growth 2017-2022 ($ Millions)
Figure 51. Southeast Asia Klebsiella Pneumoniae Infection Drug Revenue Growth 2017-2022 ($ Millions)
Figure 52. India Klebsiella Pneumoniae Infection Drug Revenue Growth 2017-2022 ($ Millions)
Figure 53. Australia Klebsiella Pneumoniae Infection Drug Revenue Growth 2017-2022 ($ Millions)
Figure 54. Europe Klebsiella Pneumoniae Infection Drug Sales Market Share by Country in 2021
Figure 55. Europe Klebsiella Pneumoniae Infection Drug Revenue Market Share by Country in 2021
Figure 56. Germany Klebsiella Pneumoniae Infection Drug Revenue Growth 2017-2022 ($ Millions)
Figure 57. France Klebsiella Pneumoniae Infection Drug Revenue Growth 2017-2022 ($ Millions)
Figure 58. UK Klebsiella Pneumoniae Infection Drug Revenue Growth 2017-2022 ($ Millions)
Figure 59. Italy Klebsiella Pneumoniae Infection Drug Revenue Growth 2017-2022 ($ Millions)
Figure 60. Russia Klebsiella Pneumoniae Infection Drug Revenue Growth 2017-2022 ($ Millions)
Figure 61. Middle East & Africa Klebsiella Pneumoniae Infection Drug Sales Market Share by Country in 2021
Figure 62. Middle East & Africa Klebsiella Pneumoniae Infection Drug Revenue Market Share by Country in 2021
Figure 63. Egypt Klebsiella Pneumoniae Infection Drug Revenue Growth 2017-2022 ($ Millions)
Figure 64. South Africa Klebsiella Pneumoniae Infection Drug Revenue Growth 2017-2022 ($ Millions)
Figure 65. Israel Klebsiella Pneumoniae Infection Drug Revenue Growth 2017-2022 ($ Millions)
Figure 66. Turkey Klebsiella Pneumoniae Infection Drug Revenue Growth 2017-2022 ($ Millions)
Figure 67. GCC Country Klebsiella Pneumoniae Infection Drug Revenue Growth 2017-2022 ($ Millions)
Figure 68. Manufacturing Cost Structure Analysis of Klebsiella Pneumoniae Infection Drug in 2021
Figure 69. Manufacturing Process Analysis of Klebsiella Pneumoniae Infection Drug
Figure 70. Industry Chain Structure of Klebsiella Pneumoniae Infection Drug
Figure 71. Channels of Distribution
Figure 72. Distributors Profiles
